| Medical and Health Sciences | 2021-2025 | 586 | DE 38 | 99.87 |
| Nephrology | Lifetime | 82 | DE 3 | 99.44 |
| Rheumatology | Lifetime | 182 | DE 13 | 99.28 |
| Immunology | Lifetime | 270 | DE 21 | 99.34 |
| Nephrology | 2021-2025 | 20 | DE 1 | 99.55 |
| Rheumatology | 2021-2025 | 54 | DE 8 | 98.80 |
| Pulmonary and Respiratory Medicine | 2021-2025 | 467 | DE 21 | 94.97 |
| Immunology | 2021-2025 | 296 | DE 24 | 92.78 |
| Endocrinology, Diabetes and Metabolism | 2021-2025 | 588 | DE 30 | 77.27 |
| Clinical Biochemistry | 2021-2025 | 73 | DE 8 | 70.42 |
| Pathology and Forensic Medicine | 2021-2025 | 560 | DE 42 | 66.37 |
| Renal Diseases and Glomerulopathies | Lifetime | 18 | DE 2 | 99.73 |
| Inflammasome and immune disorders | Lifetime | 21 | DE 3 | 99.56 |
| Systemic Lupus Erythematosus Research | Lifetime | 71 | DE 4 | 99.63 |
| Immune Response and Inflammation | Lifetime | 154 | DE 9 | 99.57 |
| Immune cells in cancer | Lifetime | 105 | DE 11 | 99.27 |
| Chemokine receptors and signaling | Lifetime | 43 | DE 4 | 99.02 |
| Neutrophil, Myeloperoxidase and Oxidative Mechanisms | Lifetime | 123 | DE 18 | 98.57 |
| Chronic Kidney Disease and Diabetes | Lifetime | 147 | DE 8 | 99.06 |
| Vasculitis and related conditions | Lifetime | 105 | DE 7 | 98.59 |
| Renal and related cancers | Lifetime | 295 | DE 15 | 98.48 |
| Phagocytosis and Immune Regulation | Lifetime | 133 | DE 12 | 97.36 |
| Muscle and Compartmental Disorders | Lifetime | 106 | DE 3 | 97.72 |
| Gout, Hyperuricemia, Uric Acid | Lifetime | 136 | DE 4 | 96.83 |
| interferon and immune responses | Lifetime | 475 | DE 42 | 96.94 |
| Acute Kidney Injury Research | Lifetime | 238 | DE 13 | 97.40 |
| Atherosclerosis and Cardiovascular Diseases | Lifetime | 557 | DE 35 | 96.58 |
| Complement system in diseases | Lifetime | 435 | DE 25 | 96.27 |
| Cytokine Signaling Pathways and Interactions | Lifetime | 839 | DE 62 | 96.04 |
| IL-33, ST2, and ILC Pathways | Lifetime | 419 | DE 32 | 96.16 |
| Kidney Stones and Urolithiasis Treatments | Lifetime | 451 | DE 20 | 95.90 |
| Liver Diseases and Immunity | Lifetime | 681 | DE 53 | 95.09 |
| Biomedical Research and Pathophysiology | Lifetime | 284 | DE 30 | 93.90 |
| Heme Oxygenase-1 and Carbon Monoxide | Lifetime | 796 | DE 42 | 93.20 |
| Biomarkers in Disease Mechanisms | Lifetime | 327 | DE 18 | 90.10 |
| Dermatological and Skeletal Disorders | Lifetime | 430 | DE 32 | 92.43 |
| Aortic Thrombus and Embolism | Lifetime | 219 | DE 13 | 85.10 |
| Case Reports on Hematomas | Lifetime | 821 | DE 29 | 69.42 |
| Renal Diseases and Glomerulopathies | 2021-2025 | 9 | DE 2 | 99.70 |
| Systemic Lupus Erythematosus Research | 2021-2025 | 37 | DE 4 | 99.03 |
| Vasculitis and related conditions | 2021-2025 | 65 | DE 3 | 97.53 |
| Chronic Kidney Disease and Diabetes | 2021-2025 | 130 | DE 8 | 96.46 |
| Dialysis and Renal Disease Management | 2021-2025 | 343 | DE 10 | 93.91 |
| Aortic Thrombus and Embolism | 2021-2025 | 10 | DE 1 | 89.47 |
| Inflammasome and immune disorders | 2021-2025 | 383 | DE 11 | 89.66 |
| Renal and related cancers | 2021-2025 | 505 | DE 23 | 87.44 |
| Liver Diseases and Immunity | 2021-2025 | 332 | DE 17 | 89.01 |
| Muscle and Compartmental Disorders | 2021-2025 | 92 | DE 7 | 85.01 |
| Acute Kidney Injury Research | 2021-2025 | 353 | DE 17 | 87.75 |
| Neutrophil, Myeloperoxidase and Oxidative Mechanisms | 2021-2025 | 450 | DE 41 | 79.24 |
| Cytokine Signaling Pathways and Interactions | 2021-2025 | 537 | DE 35 | 74.62 |
| Advanced Glycation End Products research | 2021-2025 | 369 | DE 15 | 75.82 |
| Cardiac tumors and thrombi | 2021-2025 | 698 | DE 42 | 72.08 |
| Heme Oxygenase-1 and Carbon Monoxide | 2021-2025 | 506 | DE 8 | 69.94 |
| Complement system in diseases | 2021-2025 | 865 | DE 68 | 69.83 |
| Biomedical Research and Pathophysiology | 2021-2025 | 508 | DE 36 | 49.39 |
| Macrophage Migration Inhibitory Factor | 2021-2025 | 388 | DE 35 | 48.82 |
